Drug Profile
Research programme: tubulin polymerisation inhibitors - Threshold Pharmaceuticals
Alternative Names: TH-337; TH-482; TH-494Latest Information Update: 19 Aug 2009
Price :
$50
*
At a glance
- Originator Threshold Pharmaceuticals
- Class
- Mechanism of Action Capillary permeability stimulants; Tubulin polymerisation inhibitors; Vascular disrupting agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 09 May 2007 Preclinical trials in Cancer in USA (unspecified route)